Yiping Deng
Southwest Medical University(CN)Shanghai Cell Therapy Research Institute(CN)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, Protease and Inhibitor Mechanisms, Endoplasmic Reticulum Stress and Disease, CAR-T cell therapy research, Nanoparticle-Based Drug Delivery
Most-Cited Works
- → Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis(2014)179 cited
- → Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s–PPARα axis signalling(2014)154 cited
- → Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair(2023)82 cited
- → Shedding of Syndecan–1 From Human Hepatocytes Alters Very Low Density Lipoprotein Clearance(2011)39 cited
- → Nano-modulators with the function of disrupting mitochondrial Ca2+ homeostasis and photothermal conversion for synergistic breast cancer therapy(2023)28 cited
- → Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy(2024)23 cited
- → Recent advances in curcumin-loaded biomimetic nanomedicines for targeted therapies(2023)21 cited
- → Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants(2019)16 cited
- → Roles of matrix metalloproteinase-26 in the growth, invasion and angiogenesis of breast cancer(2012)11 cited
- → Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemia(2024)10 cited